Genedata extends multi-year agreement with Nycomed

Genedata said that it will create a global scientific computing infrastructure for the lead discovery and drug research programs at Nycomed sites worldwide. Genedata Screener is expected to enable the interdisciplinary teams at all sites to rapidly capture, visualize, analyze and manage large volumes of assay data.

Werner Sturmer, head of high throughput screening at Nycomed, said: “Genedata Screener not only improves the efficiency and quality of our screening campaigns, but also has a catalytic impact on our global information network, increasing the number of users and promoting accurate and timely decisions across departments and countries.”